In-depth 15 H7N9 Human Serum Proteomics Profiling Study

Yang, Z.; Guan, W.; Zhou, S.; Chen, L.; Mok, C. K. P.; Huang, J.; Wu, S.; Zhou, H.; Liu, Y.; Peiris, J. S. M.; Liu, X.; Li, Y.; Zhong, N.

doi:10.1101/2020.01.06.896829

bioRxiv · 10.1101/2020.01.06.896829

In-depth 15 H7N9 Human Serum Proteomics Profiling Study

Yang, Z.·Guan, W.·Zhou, S.·Chen, L.·Mok, C. K. P.·Huang, J.·Wu, S.·Zhou, H.·Liu, Y.·Peiris, J. S. M.·Liu, X.·Li, Y.·Zhong, N.

View original source ↗Export metadata ↓

Abstract

BackgroundHuman infection by avian influenza viruses is characterized by rapid development of acute respiratory distress and severe pneumonia. However, the underlying host response leading to this severe outcome is not well studied. MethodsWe conducted mass spectrometry-based serum proteome profiling on 10 healthy controls and 15 H7N9 infected cases with two time points and carried out statistical and biology functional enrichment analysis. ResultsIn total, we identified 647 proteins, 273 proteins were only found in H7N9 infected cases which might generate from cell leakage/death (apoptosis and/or necrosis) and identified 50 proteins with statistically significant difference between healthy control and H7N9 infected cases from 168 qualified proteins. We also found that M1 and PB2 tightly associated with the hosts HSPA8 (P11142, p=0.0042) which plays an important role in the protein quality control system. ConclusionsH7N9 infection may increase cell programmed/unprogrammed cell death, and we suggested that upregulated extracellular HSPA8 may suppress the H7N9 virion replication via activation amyloid-beta binding network.

Explore related subjects

molecular biology Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Yang, Z., Guan, W., Zhou, S., Chen, L., Mok, C. K. P., Huang, J., Wu, S., Zhou, H., Liu, Y., Peiris, J. S. M., Liu, X., Li, Y., Zhong, N.. 2020-01-07. In-depth 15 H7N9 Human Serum Proteomics Profiling Study. https://doi.org/10.1101/2020.01.06.896829

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Fatty Acid Synthase Binds Cellular mRNAs and its Depletion Reduces Translational Efficiency

Metabolic enzymes with non-canonical RNA binding activity have drawn a growing interest, due to their implications for basic biology and disease. Here we present the first endogenous RNA interactome of fatty acid synthase (FASN), an emerging oncological and virological target. Utilizing crosslinking-based approaches, we characterize the direct RNA association of FASN in two human cell lines, identifying over 6000 binding sites across over 3500 protein-coding genes, with a striking preference for the 5' UTR. We provide a functional cross-screen on the effects of FASN depletion on cellular translation. This integration with ribosome profiling indicated a preferential reduction in the translational efficiencies of FASN-associated mRNAs - an effect shown to be dependent on binding location and site number. Associated transcripts were enriched for morphogenic and cell division-related functions, as well as palmitoylated proteins. This correlative work primes further investigation of FASN as a regulator of translation of its target mRNAs.

molecular biology↗

bioRxiv2026

Genomic features and instability of linezolid resistance in vancomycin-resistant Enterococcus faecalis ST525

This study investigated the mechanisms of oxazolidinone resistance and genomic background in clinical ST525 Enterococcus faecalis isolates, a poorly characterized lineage reported in Brazilian hospitals as either vancomycin-resistant (VRE) or linezolid- and vancomycin-resistant (LVRE). Five LVREfs from intensive care unit patients (linezolid MICs, 8-32 mg/L; vancomycin MICs, >256 mg/L) carried only G2576T and G2505A (in three of four rrl copies) as known linezolid resistance determinants, despite variable linezolid MICs. During serial in vitro passages without antibiotic pressure, isolates with initial MICs of 8-16 mg/L exhibited progressive MIC reductions accompanied by reversion of mutant to wild-type rrl copies, whereas the isolate with an initial MIC of 32 mg/L maintained high-level resistance without reversion. Additional domain V substitutions emerged during MIC decline, while growth kinetics remained broadly similar. Whole-genome sequencing of a representative isolate (LVREfs L7) revealed a ~2.8-Mb chromosome enriched in mobile genetic elements (~8.6%), lacking a functional CRISPR-Cas system. A plasmid-borne prototype Tn1546 carrying vanA, devoid of internal insertion sequences, was found inserted into a Tn3-family transposase gene, a platform not typically associated with vanA mobilization. Together, these findings indicate that ST525 LVREfs, whose genomic features are consistent with long-term persistence in hospitals, may pose a challenge to routine susceptibility testing. A single mutational mechanism can yield variable linezolid MICs, and the ratio of mutated vs wild-type rrl copies can become heterogeneous in the absence of antibiotic pressure, without correlating directly with these values, contrary to the well-documented copy number-MIC correlation.

molecular biology↗

bioRxiv2026

Global repression of mesenchymal genes in epithelial cells by the histone demethylase LSD1

Epithelial-mesenchymal transition (EMT) is an essential process in development, tissue repair, and tumour metastasis, and is triggered by SNAI, ZEB and TWIST transcription factors, that recruit lysine-specific demethylase 1 (LSD1) to repress epithelial genes such as E-cadherin. In mesenchymal cells, LSD1 inhibition restores E-cadherin expression and reduces migration and invasion, consistent with LSD1 inhibition reverting EMT, and offering a therapeutic modality for EMT-associated disease. Recent data, however, suggest context-dependent roles for LSD1, as its inhibition in epithelial cells increases mesenchymal marker expression, potentially promoting EMT. To investigate this discrepancy, we mapped genome-wide binding of LSD1 in HCT116 epithelial cells and used rapid degron-mediated ablation of endogenous LSD1 to measure changes in nascent and steady-state transcription and chromatin accessibility. In epithelial cells, LSD1 binds constitutively-accessible, primed mesenchymal promoters. These are rapidly derepressed after LSD1 ablation, with activation of SNAI2 and ZEB1, which repress epithelial hallmarks such as E-cadherin. Re-introduction of LSD1 downregulates SNAI2 and ZEB1 but, surprisingly, further represses E-cadherin, indicating sustained loss of epithelial characteristics. Collectively, our results show that LSD1 maintains epithelial identity by repressing mesenchymal genes, questioning the therapeutic utility of LSD1 inhibition for EMT control.

molecular biology↗